Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Sell
-2,954
Closed -$248K 561
2025
Q3
$248K Buy
+2,954
New +$243K 0.14% 313
2024
Q4
Sell
-3,330
Closed -$378K 245
2024
Q3
$378K Sell
3,330
-3,565
-52% -$424K 0.21% 206
2024
Q2
$854K Buy
+6,895
New +$888K 0.52% 19
2024
Q1
Sell
-4,250
Closed -$463K 606
2023
Q4
$463K Sell
4,250
-4,588
-52% -$476K 0.26% 141
2023
Q3
$910K Buy
+8,838
New +$953K 0.55% 17
2023
Q2
Sell
-4,879
Closed -$519K 545
2023
Q1
$519K Buy
+4,879
New +$527K 0.33% 86
2022
Q4
Sell
-3,239
Closed -$279K 510
2022
Q3
$279K Buy
+3,239
New +$289K 0.18% 249
2022
Q2
Sell
-2,693
Closed -$221K 504
2022
Q1
$221K Sell
2,693
-816
-23% -$64.3K 0.18% 275
2021
Q4
$269K Buy
+3,509
New +$279K 0.43% 111

Other funds holding MRK

MQS Management's MRK Position: Q4 2025 in Review

MQS Management sold out of Merck (MRK) in Q4 2025, closing a stake of 2,954 shares — an estimated $248K sold.

MQS Management first reported a position in MRK in Q4 2021 and held it in 9 quarters. The position peaked at $910K in Q3 2023. 3,660 funds tracked by Wall St. Rank hold MRK as of Q4 2025.

  • MQS Management reported no remaining Merck position as of Q4 2025 after selling out during the quarter.
  • MQS Management sold 2,954 Merck shares in Q4 2025, an estimated $248K.
  • MQS Management first reported a position in Merck in Q4 2021 and held it in 9 quarters.
  • MQS Management's Merck position peaked at $910K in Q3 2023.
  • 3,660 funds tracked by Wall St. Rank held Merck as of Q4 2025.

Based on MQS Management's 13F filing for Q4 2025, filed 9 Feb 2026.